(Q46046670)

19 December 2017

title

The effect of HAART on salivary microbiota in the Women's Interagency HIV Study (WIHS). (English)

1 reference

19 December 2017

author name string

Mavash Navazesh

1

1 reference

19 December 2017

Roseann Mulligan

2

1 reference

19 December 2017

Janice Pogoda

3

1 reference

19 December 2017

Deborah Greenspan

4

1 reference

19 December 2017

Mario Alves

5

1 reference

19 December 2017

Joan Phelan

6

1 reference

19 December 2017

John Greenspan

7

1 reference

19 December 2017

Jorgen Slots

8

1 reference

19 December 2017

publication date

25 January 2005

1 reference

19 December 2017

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

19 December 2017

volume

100

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

701-708

1 reference

19 December 2017

The epidemiology of the oral lesions of HIV infection in the developed world

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

7 January 2021

HIV-related oral disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Differences in risk factors among clinical types of oral candidiasis in the Women's Interagency HIV Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Oral Lesions in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment Including Protease Inhibitors: A New Face of Oral AIDS?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Adverse effects of antiretroviral therapy: focus on orofacial effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Self-reported oral dryness and HIV disease in a national sample of patients receiving medical care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

HIV topic update: protease inhibitor therapy and oral health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Salivary gland disease in human immunodeficiency virus-positive women from the WIHS study. Women's Interagency HIV Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

The significance and management of periodontal lesions in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Oral manifestations associated with human immunodeficiency virus infection in a Spanish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Oral signs and symptoms in 160 Greek HIV‐infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

An update on HIV and periodontal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Effect of highly active antiretroviral therapy on frequency of oral warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Immune reconstitution in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Alteration in salivary function in early HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Salivary anticandidal activity and saliva composition in an HIV-infected cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Longitudinal study of parotid saliva in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Salivary albumin, total protein, IgA, IgG and IgM concentrations and occurrence of some periodontopathogens in HIV-infected patients: a 2-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

The habitat of periodontopathic micro-organisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Baseline characteristics of participants in the oral health component of the Women's Interagency HIV Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Clinical criteria for the diagnosis of salivary gland hypofunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Rapid identification of important periodontal microorganisms by cultivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Longitudinal data analysis for discrete and continuous outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Microbial etiological agents of destructive periodontal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Risk indicators for harboring periodontal pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

The utility of whole saliva to detect the oral presence of periodontopathic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Modulation of the host response in periodontal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Salivary levels of suspected periodontal pathogens in relation to periodontal status and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Update on human cytomegalovirus in destructive periodontal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Limited immune reconstitution at intermediate stages of HIV-1 infection during one year of highly active antiretroviral therapy in antiretroviral-naive versus non-naive adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

HAART and Mycobacterium avium complex in an HIV infected patient with severe factor VII deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

The Naive CD4+ Count in HIV-1-infected Patients at Time of Initiation of Highly Active Antiretroviral Therapy is Strongly Associated with the Level of Immunological Recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Incidence of oral lesions in HIV-1-infected women: reduction with HAART.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

Oral manifestations associated with human immunodeficiency virus (HIV) infection in developing countries--are there differences from developed countries?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

7 January 2021

Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

7 January 2021

Proficiencies of three anaerobic culture systems for recovering periodontal pathogenic bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

7 January 2021

Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2004.10.011

7 January 2021

10.1016/J.TRIPLEO.2004.10.011

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017